Categories
Activities All-en Hepatitis-en

Yayasan Peduli Hati Bangsa attended World Hepatitis Summit 2024

The World Hepatitis Summit (WHS) 2024 takes place on April 9-11 in Lisbon, Portugal. The activity is organized by the World Hepatitis Alliance (WHA), co-sponsored by the World Health Organization (WHO), and supported by the Portuguese Ministry of Health. The Summit featured more than 30 sessions, side meetings, plenaries and workshops, and was attended by…

Categories
Activities All-en Hepatitis-en HepC-en

Fixed dose combination Hepatitis medicine is available.

Currently, anti-Hepatitis C virus medicines are available in the form of fixed dose combinations. The medicine is only taken once of 1 pill a day. Others, which is not a combination dose are available but only for 2 months. If you need testing and treatment for Hepatitis C, both in general population or in a…

Categories
All-en Hepatitis-B-en Hepatitis-en HepC-en Reports-en

Global increase in deaths from viral hepatitis revealed in WHO report

By: The World Health Organization, 10 April 2024 According to the World Health Organization (WHO) 2024 Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing. The disease is the second leading infectious cause of death globally — with 1.3 million deaths per year, the same as tuberculosis, a top infectious…

Categories
All-en Hepatitis-en HepC-en

A link between diabetes and hepatitis C

by: Peduli Hati Bangsa team (May 2024) The hepatitis C virus (HCV) spreads through contact with blood. This can cause acute or chronic infections. If HCV becomes chronic, the infection can cause liver damage and the development of other conditions, including diabetes. Numerous studies show a correlation between HCV and diabetes. Up to 33% of…

Categories
All-en doc-library-en Hepatitis-B-en Hepatitis-en News-en

WHO publishes a new guideline for hepatitis B

By: Tim Yayasan Peduli Hati Bangsa, 23 April 2024 WHO has released new Guidelines on the prevention, diagnosis and treatment of chronic hepatitis B (HBV) infection at the Asia Pacific Conference for the Study of Liver Diseases (APASL) 2024 in Kyoto, Japan. Recommendations from these guidelines were also presented at the 2024 World Hepatitis Summit…